ES494507A0 - Un metodo para la preparacion de derivados de ftalimidina - Google Patents

Un metodo para la preparacion de derivados de ftalimidina

Info

Publication number
ES494507A0
ES494507A0 ES494507A ES494507A ES494507A0 ES 494507 A0 ES494507 A0 ES 494507A0 ES 494507 A ES494507 A ES 494507A ES 494507 A ES494507 A ES 494507A ES 494507 A0 ES494507 A0 ES 494507A0
Authority
ES
Spain
Prior art keywords
preparation
phthalimidine
derivatives
phthalimidine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES494507A
Other languages
English (en)
Other versions
ES8104275A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astra Lakemedel AB
Original Assignee
Astra Lakemedel AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Lakemedel AB filed Critical Astra Lakemedel AB
Publication of ES8104275A1 publication Critical patent/ES8104275A1/es
Publication of ES494507A0 publication Critical patent/ES494507A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES494507A 1979-08-27 1980-08-26 Un metodo para la preparacion de derivados de ftalimidina Granted ES494507A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7907121A SE7907121L (sv) 1979-08-27 1979-08-27 Ftalimidinderivat

Publications (2)

Publication Number Publication Date
ES8104275A1 ES8104275A1 (es) 1981-04-01
ES494507A0 true ES494507A0 (es) 1981-04-01

Family

ID=20338703

Family Applications (6)

Application Number Title Priority Date Filing Date
ES494508A Granted ES494508A0 (es) 1979-08-27 1980-08-26 Un metodo para la preparacion de derivados de ftalimidina
ES494507A Granted ES494507A0 (es) 1979-08-27 1980-08-26 Un metodo para la preparacion de derivados de ftalimidina
ES494502A Expired ES8103743A1 (es) 1979-08-27 1980-08-26 Un metodo para la preparacion de derivados de ftalimidina
ES494504A Granted ES494504A0 (es) 1979-08-27 1980-08-26 Un metodo para la preparacion de derivados de ftalimidina
ES494505A Expired ES8106721A1 (es) 1979-08-27 1980-08-26 Un metodo para la preparacion de derivados de ftalimidina
ES494506A Granted ES494506A0 (es) 1979-08-27 1980-08-26 Un metodo para la preparacion de derivados de ftalimidina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES494508A Granted ES494508A0 (es) 1979-08-27 1980-08-26 Un metodo para la preparacion de derivados de ftalimidina

Family Applications After (4)

Application Number Title Priority Date Filing Date
ES494502A Expired ES8103743A1 (es) 1979-08-27 1980-08-26 Un metodo para la preparacion de derivados de ftalimidina
ES494504A Granted ES494504A0 (es) 1979-08-27 1980-08-26 Un metodo para la preparacion de derivados de ftalimidina
ES494505A Expired ES8106721A1 (es) 1979-08-27 1980-08-26 Un metodo para la preparacion de derivados de ftalimidina
ES494506A Granted ES494506A0 (es) 1979-08-27 1980-08-26 Un metodo para la preparacion de derivados de ftalimidina

Country Status (12)

Country Link
US (1) US4289781A (es)
EP (1) EP0026749A1 (es)
JP (1) JPS5634679A (es)
AU (1) AU6151380A (es)
DK (1) DK365280A (es)
ES (6) ES494508A0 (es)
FI (1) FI802686A (es)
IL (1) IL60478A0 (es)
NO (1) NO802215L (es)
SE (1) SE7907121L (es)
SU (1) SU969164A3 (es)
ZA (1) ZA804057B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1169078A (en) * 1980-12-29 1984-06-12 Michael J. Fifolt Method for the preparation of fluorophthalamic compounds
ZA83508B (en) * 1982-01-27 1983-10-26 Britax Wingard Ltd Ferrule attachment
EP0093488A3 (en) * 1982-03-18 1984-05-23 Beecham Group Plc Nortropyl benzopyrrolinone compounds, process for their preparation and pharmaceutical compositions containing them
US4495194A (en) * 1982-11-12 1985-01-22 Mead Johnson & Company Antihypertensive isoindole derivatives
US4600758A (en) * 1982-11-12 1986-07-15 Mead Johnson & Company Isoindole derivatives
US4505911A (en) * 1983-10-13 1985-03-19 Mead Johnson & Company Isoindole diuretic derivatives, compositions and use
US4585773A (en) * 1984-07-11 1986-04-29 Bristol-Myers Company Isoindolinyl-alkyl-piperazines
JPS6169773A (ja) * 1984-09-14 1986-04-10 Takeda Chem Ind Ltd イソインドリノン誘導体
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
EP0351283A1 (fr) * 1988-07-12 1990-01-17 Synthelabo Dérivés de [(pipéridinyl-4) méthyl]-2 dihydro-2,3 1H-isoindole et tétrahydro-2,3,4,5 1H-benzazépines, leur préparation et leur application en thérapeutique
US5070094A (en) * 1989-09-05 1991-12-03 G. D. Searle & Co. N-benzyltropaneamides
US5028616A (en) * 1989-09-05 1991-07-02 G. D. Searle & Co. N-benzylpiperidine amides
US5210090A (en) * 1989-09-05 1993-05-11 G. D. Searle & Co. Substituted N-benzylpiperidine amides and cardiac regulatory compositions thereof
US4992446A (en) * 1989-09-05 1991-02-12 G. D. Searle & Co. Tricyclic quinolizine amides
US5053413A (en) * 1989-09-05 1991-10-01 G. D. Searle & Co. N-benzylpiperidineisoindolinones
US5098915A (en) * 1989-09-05 1992-03-24 G. D. Searle & Co. Substituted N-benzylpiperidine amides
ZA908641B (en) * 1989-10-27 1992-06-24 Du Pont (n-phthalimidoalkyl)piperidines
US5356906A (en) * 1989-10-27 1994-10-18 The Du Pont Merck Pharmaceutical Company (N-phthalimidoalkyl) piperidines useful as treatments for psychosis
JP2807577B2 (ja) * 1990-06-15 1998-10-08 エーザイ株式会社 環状アミド誘導体
US5162341A (en) * 1991-02-22 1992-11-10 Du Pont Merck Pharmaceutical Company Use of sigma receptor antagonists for treatment of amphetamine abuse
US5739135A (en) * 1993-09-03 1998-04-14 Bristol-Myers Squibb Company Inhibitors of microsomal triglyceride transfer protein and method
US5567718A (en) * 1994-08-11 1996-10-22 Hoechst Marion Roussel Inc. 2,3-dihydro-1h-isoindole derivatives and their use as serotonin reuptake inhibitors
US5827875A (en) * 1996-05-10 1998-10-27 Bristol-Myers Squibb Company Inhibitors of microsomal triglyceride transfer protein and method
US5885983A (en) * 1996-05-10 1999-03-23 Bristol-Myers Squibb Company Inhibitors of microsomal triglyceride transfer protein and method
US5883109A (en) * 1996-07-24 1999-03-16 Bristol-Myers Squibb Company Method for lowering serum lipid levels employing an MTP inhibitor in combination with another cholesterol lowering drug
US5760246A (en) 1996-12-17 1998-06-02 Biller; Scott A. Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
WO2000000472A1 (en) 1998-06-30 2000-01-06 Du Pont Pharmaceuticals Company 5-ht7 receptor antagonists
FI20021421A0 (fi) * 2002-07-30 2002-07-30 Orion Corp Fermion Valmistusmenetelmä
US6881815B2 (en) * 2002-09-25 2005-04-19 General Electric Company Method for the preparation poly(etherimide)s
TW200918062A (en) * 2007-09-12 2009-05-01 Wyeth Corp Azacyclylisoquinolinone and-isoindolinone derivatives as histamine-3 antagonists
US8278302B2 (en) 2009-04-08 2012-10-02 Boehringer Ingelheim International Gmbh Substituted piperidines as CCR3 antagonists
UA109290C2 (uk) 2010-10-07 2015-08-10 Спільні кристали і солі інгібіторів ccr3
US8680280B2 (en) 2012-04-02 2014-03-25 Boehringer Ingelheim International Gmbh Process for the manufacturing of CRR inhibitors
US10213421B2 (en) 2012-04-04 2019-02-26 Alkahest, Inc. Pharmaceutical formulations comprising CCR3 antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE333734B (es) 1969-04-23 1971-03-29 Kabi Ab
IL34317A0 (en) 1969-04-23 1970-06-17 Kabi Ab Substituted acetamides,their preparation and pharmaceutical compositions containing them
GB1486104A (en) 1975-01-23 1977-09-21 Wyeth John & Brother Ltd Phthalimidopiperidine derivatives
US4053615A (en) * 1972-10-21 1977-10-11 John Wyeth & Brother Limited Phthalimidopiperidines and anti-convulsant compositions thereof
GB1425578A (en) * 1972-10-21 1976-02-18 Wyeth John & Brother Ltd Piperidine derivatives
US4000287A (en) * 1974-12-16 1976-12-28 Ciba-Geigy Corporation Isoindolinopiperidines

Also Published As

Publication number Publication date
ES494505A0 (es) 1981-08-01
EP0026749A1 (en) 1981-04-08
ES8104275A1 (es) 1981-04-01
ES8106722A1 (es) 1981-08-01
SE7907121L (sv) 1981-02-28
IL60478A0 (en) 1980-09-16
JPS5634679A (en) 1981-04-06
ES8103744A1 (es) 1981-03-16
ES8106723A1 (es) 1981-08-01
NO802215L (no) 1981-03-02
ES8106721A1 (es) 1981-08-01
FI802686A (fi) 1981-02-28
ES494504A0 (es) 1981-03-16
ZA804057B (en) 1981-07-29
AU6151380A (en) 1981-03-05
ES494506A0 (es) 1981-08-01
DK365280A (da) 1981-02-28
ES494508A0 (es) 1981-08-01
ES494502A0 (es) 1981-03-16
US4289781A (en) 1981-09-15
ES8103743A1 (es) 1981-03-16
SU969164A3 (ru) 1982-10-23

Similar Documents

Publication Publication Date Title
ES494505A0 (es) Un metodo para la preparacion de derivados de ftalimidina
ES505548A0 (es) Un procedimiento para la preparacion de nuevos derivados de diarilaminofluorano
ES504103A0 (es) Un procedimiento para la preparacion de derivados de hidan- toina
AR222204A1 (es) Un procedimiento para la preparacion de derivados de i-bencilimidazol
ES502792A0 (es) Un procedimiento para la preparacion de derivados de imida- zol
ES502994A0 (es) Un procedimiento para la preparacion de derivados de pirazo-lopiridacina
ES497640A0 (es) Un procedimiento para la preparacion de derivados de la 7- amino-4-trifluormetilcumarina
ES489752A0 (es) Un procedimiento para la preparacion de un derivado de imi- dazolidindiona
ES499559A0 (es) Un procedimiento para la preparacion de derivados de pirrol
ES501805A0 (es) Un procedimiento para la preparacion de derivados de la eta-nolamina
ES496798A0 (es) Un procedimiento para la preparacion de un derivado de aze- tidina
ES500382A0 (es) Un procedimiento para la preparacion de derivados de triazo-lopiridazina
ES490510A0 (es) Un procedimiento para la preparacion de derivados de penici-lina
ES496487A0 (es) Un procedimiento para la preparacion de nuevos derivados hi-droxialquil-triazoles
ES505555A0 (es) Un procedimiento para la preparacion de derivados de imida- zol
ES495865A0 (es) Un procedimiento para la preparacion de derivados de quina- zolina
ES491992A0 (es) Un procedimiento para la preparacion de nuevos derivados de hidroxiamino-eburnano
ES490289A0 (es) Un procedimiento para la preparacion de derivados de xantina
ES494091A0 (es) Un procedimiento para la preparacion de derivados de pirro- lidina
ES500911A0 (es) Un procedimiento para la preparacion de derivados de ergoli-na
ES495102A0 (es) Un procedimiento para la preparacion de un derivado de iminohalogenuro
AR222208A1 (es) Un procedimiento para la preparacion de derivados de 4-amino-2-piperidino-quinazolina
ES498145A0 (es) Un procedimiento para la preparacion de derivados de metoxi-cefalosporinas
ES489227A0 (es) Un procedimiento para la preparacion de un derivado de pira-zol
ES497775A0 (es) Un procedimiento para la preparacion de nuevos derivados de dihidropiridina